Novavax AB has a total of 14 patent applications. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are NOVARX, ISCONOVA AB and ONYVAX LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Morein Bror | 14 |
#2 | Lövgren Bengtsson Karin | 7 |
#3 | Ekström Jill | 5 |
#4 | Ranlund Katarina | 5 |
#5 | Hu Kefei | 5 |
#6 | Osterhaus A D M E | 3 |
#7 | Bengtsson Lövgren Karin | 2 |
#8 | Lovgren Bengtsson Karin | 1 |
#9 | Lövgren-Bengtsson Karin | 1 |
#10 | Lovgren-Bengtsson Karin | 1 |